Omnicell, Inc. (FRA:OC9)

Market Cap	1.64B +39.3%
Revenue (ttm)	1.06B +7.9%
Net Income	17.72M -3.5%
EPS	0.38 -2.8%
Shares Out	n/a
PE Ratio	92.37
Forward PE	22.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	35.40
Previous Close	36.40
Day's Range	35.40 - 35.40
52-Week Range	22.80 - 43.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-hous...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1992
• Employees: 3,525
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC9

Financial Performance

In 2025, Omnicell's revenue was $1.18 billion, an increase of 6.53% compared to the previous year's $1.11 billion. Earnings were $2.05 million, a decrease of -83.62%.

Financial numbers in USD